Recent News
Winding Down This Week: The Acurx Crossover Round
Clostridoides difficile BioPub reader participation in the pre-IPO funding rounds for Acurx has been unsurpassed. We thought we’d nag ever-so-slightly and remind you that this present crossover round …
BioPub Elects Dr. Jerry Silver “Evergreen” Scientist of the Year
Jerry Silver, PhD Professor of Neurosciences Case Western Reserve University Scientific Founder NervGen Earlier in 2020, BioPub editors voted Dr. Mei-Mei Tian, Vice President of …
From Copacetic to Caput at Soleno?
Soleno CEO Anish Bhatnagar, MD By now you probably know the long-vaunted phase 3 trial of a proprietarily-compounded version of old drug diazoxide has failed …
The Greening of StemoniX
StemoniX Co-Founder Ping Yeh It was a chance meet-up under a shade tree on a veranda…..the grounds of the hopelessly ornate hotel at Laguna Niguel, …
CANCELLED: The ImmunoPhotonics Encore
ImmunoPhotonics Co-Founder Tomas Hode, PhD Remember Gabriella and the Goop? Gabriella was the cat cured of a rare oral tumor, deemed incurable and aggressive in …
KSS Portfolio June 2020
KSS, New York City, October 2018 “Did you get your disconnection notice? Mine came in the mail today They seem to think I’m disconnected Don’t …
On the Eve of a Major Phase 2b Data Read, Cleveland Contemplates the Antibe ($ATBPF) Phenomenon
Antibe Therapeutics CEO Dan Legault, JD When the editors of BioPub placed Toronto biotech Antibe Therapeutics conspicuously in our annual “12 Biotechs of Christmas” list for 2020, we did …
lgernon IV: The BioPub TV Miniseries (Monday, 1 June, Noon EST)
Christopher Moreau, CEO, Algernon ($AGNPF) BioPub is proud to be continuing to champion the advancement, the onslaught, the advent of firecracker Canadian pharma firm Algernon….where the …
Tony Pullen on the Fiasco that is DiaMedica ($DMCAF)
For a former girlfriend (adventurous sort) and me, it was a journey of the soul too important to be bucket-listed. Most of the great travels …
Jon Stern Retires from CohBar
Jon Stern, retiring as COO of CohBar For most of us who’ve worked with CohBar these years, no face or voice is more default-associated with …
The BioPub Options Discussion Thread
Some readers have asked for an options discussion thread…..so, voila. Call options allow you prospectively to have access to more shares for less investment, but …
An Open Letter To LexaGene CEO Dr. Jack Regan from the BioPub
Jack Regan, PhD CEO, LexaGene Dear Jack: We delight in your press release from this morning and congratulate you and your colleagues, as we know …
Join The BioPub
Community
Register now and gain access to our medical and science forums.
BIOPUB Webcasts
BioPub is the only biotech investing forum regularly providing readers top-tier unfettered live access to biotech executives…in the form of live webcasts once or twice weekly with new companies that have evoked editorial attention and established companies in the BioPub stable of investments. Our copyrighted, exclusive webcasts are recorded and archived on this website and sometimes on our youtube channel. Have a question for which the answer will influence your investment decision? Show up and ask.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
BIOPUB Webcasts
BioPub is the only biotech investing forum regularly providing readers top-tier unfettered live access to biotech executives…in the form of live webcasts once or twice weekly with new companies that have evoked editorial attention and established companies in the BioPub stable of investments. Our copyrighted, exclusive webcasts are recorded and archived on this website and sometimes on our youtube channel. Have a question for which the answer will influence your investment decision? Show up and ask.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
BioPub
a publication of Helixir Media, LLC
- KSS, MD, PhD, (New York): Founder
- Alan Harris (London): Founder
- KSS, MD, PhD, FACP: Editor-in-Chief and Publisher
- Jonathan Coulborn, MBA: Editor
- Glenn Newberry: Editor-at-Large
- Cleveland: Contributing Editor
- cw99, MD: Associate Editor
- Paul Harte: Associate Editor
- OneMdcn: Associate Editor
EDITORIAL BOARD
- Jonathan Coulborn: MBA, Chairman
- Tom Nall: Tampa, Florida
- cw99, MD: Austin, TX
- KSS, MD, PhD: ex officio
- Paul Harte: San Francisco, CA
- Melanie, MS: New York, NY
